GlassScriptPhysician profile
Michelle L Walker
NPI 1811393788
$4,392.80
in general payments reported to CMS, 2019-2025
28 companies · $943 in 2025
The $943 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $464 · 2022: $1,283 · 2023: $905 · 2024: $798 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,645.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,036.50 | 2021-2025 | |
| Abbott Laboratories | $1,017.49 | 2021-2025 | Proclaim, Eterna, Octrode |
| Collegium Pharmaceutical, INC. | $763.19 | 2021-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $416.88 | 2021-2025 | Relistor |
| Amgen INC. | $148.56 | 2021-2022 | |
| Pfizer INC. | $131.87 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $92.66 | 2022-2023 | Ztlido |
| Allergan, INC. | $79.94 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $71.68 | 2023-2024 | Horizant, Horizant |
| Curonix LLC | $69.29 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $64.85 | 2023-2024 | Qutenza |
| Protega Pharmaceutials INC | $64.31 | 2022-2025 | Roxybond |
| Lundbeck LLC | $48.23 | 2025 | Vyepti |
| Lilly USA, LLC | $47.76 | 2022-2025 | Jardiance, Emgality |
| Biohaven Pharmaceuticals, INC. | $42.09 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $33.57 | 2022 | |
| Grt US Holding, INC. | $32.57 | 2021 | |
| Biodelivery Sciences International, INC. | $30.91 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.60 | 2022 | |
| Boston Scientific Corporation | $23.48 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.49 | 2025 | Jardiance |
| Tersera Therapeutics LLC | $20.09 | 2023 | Prialt |
| Hikma Pharmaceuticals USA | $19.47 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.41 | 2022 | |
| Stimwave Technologies Incorporated | $18.75 | 2022 | |
| Almatica Pharma LLC | $16.84 | 2021 | |
| Ibsa Pharma INC. | $15.53 | 2025 | Tirosint, Flector, Licart |
| Genentech USA, INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.